You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

CLINICAL TRIALS PROFILE FOR FOLVITE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for FOLVITE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02318446 ↗ Efficacy Study of Folic Acid Supplementation in Adolescent Epileptics Unknown status Maharashtra University of Health Sciences Phase 3 2015-03-01 The present study is planned to study effect of folic acid supplementation on homocysteine levels and CV risk factors such as BP and lipids in adolescent epileptics taking anti-epileptic drugs (AEDs).
NCT02930343 ↗ Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate Monotherapy Terminated Jawaharlal Institute of Postgraduate Medical Education & Research Phase 3 2016-09-01 RA (Rheuatoid arthritis) is a multisystem disease that mainly involves joints resulting in destructive arthritis if not treated rapidly. Inspite of various advances in field of early diagnosis and treatment of RA, there is still a need for better understanding of the efficacy and safety of various combinations of conventional DMARDS, and to rank them in order accordingly, so as to give a clearer vision for further management of RA once MTX monotherapy fails, so as to achieve remission as soon as possible. The study will be conducted at the Department of Clinical Immunology, JIPMER (Jawaharlal Institute of Postgraduate Medical Education & Research). patients who fail methotrexate monotherapy will be randomised to 2 treatment arms - either a combination of Sulfasalazine (SSZ), Hydroxychloroquine (HCQ) and Methotrexate (MTX) or Leflunomide (LEF), Hydroxychloroquine (HCQ) and Methotrexate (MTX)
NCT03193788 ↗ Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based Chemotherapy Unknown status Korean Cancer Study Group Phase 3 2017-01-01 This study aims to verify superiority of pemetrexed maintenance to observation for patient without disease progression after 1 st line cisplatin-based chemotherapy.
NCT03193788 ↗ Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based Chemotherapy Unknown status Asan Medical Center Phase 3 2017-01-01 This study aims to verify superiority of pemetrexed maintenance to observation for patient without disease progression after 1 st line cisplatin-based chemotherapy.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for FOLVITE

Condition Name

Condition Name for FOLVITE
Intervention Trials
Bladder Cancer 1
Epilepsy 1
Rheumatoid Arthritis 1
Transitional Cell Carcinoma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for FOLVITE
Intervention Trials
Carcinoma, Transitional Cell 1
Carcinoma 1
Arthritis, Rheumatoid 1
Arthritis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for FOLVITE

Trials by Country

Trials by Country for FOLVITE
Location Trials
India 2
Korea, Republic of 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for FOLVITE

Clinical Trial Phase

Clinical Trial Phase for FOLVITE
Clinical Trial Phase Trials
Phase 3 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for FOLVITE
Clinical Trial Phase Trials
Unknown status 2
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for FOLVITE

Sponsor Name

Sponsor Name for FOLVITE
Sponsor Trials
Maharashtra University of Health Sciences 1
Jawaharlal Institute of Postgraduate Medical Education & Research 1
Korean Cancer Study Group 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for FOLVITE
Sponsor Trials
Other 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.